Marco A. Cimmino

POS0082 EXPLORING THE GENETIC BASIS OF CLINICAL HETEROGENEITY IN GIANT CELL ARTERITIS

OP0102 IDENTIFICATION OF NEW RISK LOCI AND PATHWAYS INVOLVED IN GCA PATHOGENESIS BY A GENOME-WIDE STUDY

Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data

A seasonal pattern in the onset of polymyalgia rheumatica and giant cell arteritis? A systematic review and meta-analysis

Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course

AB0893 WHAT IS THE CHANCE IN AN INDIVIDUAL GOUTY PATIENTTHAT DISEASE WILL BE STILL ACTIVE IN A YEAR? PREDICTIVE MODELLING MIGHT COME TO AID

Timing of onset affects arthritis presentation pattern in antisyntethase syndrome.

Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy

Performance of Ultrasound in the Diagnosis of Gout in a Multicenter Study: Comparison With Monosodium Urate Monohydrate Crystal Analysis as the Gold Standard

A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis

Survey Definitions of Gout for Epidemiologic Studies: Comparison With Crystal Identification as the Gold Standard

Development and First Validation of a Disease Activity Score for Gout

Lifestyle and dietary habits of patients with gout followed in rheumatology settings

2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

2015 Recommendations for the Management of Polymyalgia Rheumatica: A European League Against Rheumatism/American College of Rheumatology Collaborative Initiative

A Large-Scale Genetic Analysis Reveals a Strong Contribution of the HLA Class II Region to Giant Cell Arteritis Susceptibility

Study for Updated Gout Classification Criteria: Identification of Features to Classify Gout

Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises

Ultrasound-guided procedures around the wrist and hand: How to do

Performance of classification criteria for gout in early and established disease

FRI0295 Rituximab Retention Rate in Clinical Practice: A Large Multicentre Italian Cohort of Rheumatoid Arthritis Patients

SAT0501 Clinical Predictors of Functional Disability in Patients with Gout: Analysis from A Multicentre Observational Study of the Italian Society for Rheumatology

Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR)

The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study

Orchestration of Inflammation and Adaptive Immunity in <i>Borrelia burgdorferi</i>–Induced Arthritis by Neutrophil‐Activating Protein A

High frequency of capsular knee involvement in polymyalgia rheumatica/giant cell arteritis patients studied by positron emission tomography

OP0003 Development and Preliminary Validation of a Candidate Disease Activity Score for Gout

2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockers

AB0311 The 158vv fcgamma receptor iiia genotype predicts a positive response to rituximab in rheumatoid arthritis: Analysis in a large cohort of italian patients